XBIT earnings date and last-quarter result: last quarter miss, P/E -1.72. Updated 2026-07-23.
XBiotech (XBIT) Research Hub
XBiotech (XBIT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.85 USD (-4.15%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.72, market cap 0.07B. This hub links to the full technical, earnings and options research available for XBIT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.85 USD (-4.15%) |
| 52-week range | 1.82 USD – 2.47 USD |
| Trend regime | Range |
| 14-day RSI | 24.6 (Oversold) |
| Trailing P/E | -1.72 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
Available research for XBIT
Covered Call on XBIT: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XBIT: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XBIT: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
XBIT technical analysis: range, last 1.85 USD, RSI 24.6, 52w range 1.82 USD–2.47 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is XBIT in?
XBiotech (XBIT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XBIT in an uptrend or downtrend?
As of 2026-10-26, XBIT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XBIT's trailing P/E ratio?
XBIT's trailing P/E is -1.72, with a market cap of 0.07B. See the earnings research page for full valuation detail.